Latest Press Releases

Philips Unveils Next-generation BlueSeal helium-free MRI system, Integrated with AI-enabled Smart Reading at #RSNA24

Nov. 21, 2024 Industry’s first wide bore, high-performance helium-free [1] 1.5T MR features AI assistance at every step in the MRI workflow, with seamless integration of cloud-based AI image reading and reporting tools on the MR scanner ...

Boehringer’s focus on Health Equity drives significant upgrade in Access to Medicine Index Ranking

Boehringer Ingelheim, a leading research-driven biopharmaceutical company, has been lifted to 8th place in the 2024 Access to Medicine Index (ATMI), up from 13th in 2022. This improvement reflects the company's strategic shift of prioritizing ...

SurgiBox Announces Strategic Partnership with Accord International to Expand into Japanese Market

TOKYO, Nov. 17, 2024 (GLOBE NEWSWIRE) -- SurgiBox Inc., a leader in portable surgical solutions, is thrilled to announce a strategic partnership with Japanese medical distribution company, Accord International, to bring its groundbreaking ...

KFSHRC Introduces Pioneering Virtual Pathology Services in Madinah

RIYADH, Saudi Arabia, Nov. 17, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) has unveiled its state-of-the-art Virtual Pathology Service at the Madinah branch, revolutionizing the field of anatomical ...

Foresee Pharmaceuticals Receives the Second Positive Recommendation from DSMB to Continue the Casppian Study, a Phase 3 Clinical Trial of Leuprolide (FP-001) Injectable Emulsion for the Treatment of Central Precocious Puberty

PR Newswire TAIPEI, Nov. 15, 2024 TAIPEI, Nov. 15, 2024 /PRNewswire/ -- Foresee Pharmaceuticals (TPEx: 6576), ("Foresee") today announces the second positive safety review by the independent Data and Safety Monitoring Board for its Casppian ...

Immunovia presents model-development study results at meeting of the Collaborative Group of the Americas--Inherited Gastrointestinal Cancers

PR Newswire PHILADELPHIA, Nov. 15, 2024 PHILADELPHIA, Nov. 15, 2024 /PRNewswire/ -- Immunovia (NASDAQ Stockholm: IMMNOV), the pancreatic cancer diagnostics company, will present results from the recently completed model-development study of ...

Noster Inc research: Celebrating Breakthroughs in Gut Microbiome

PR Newswire KYOTO, Japan, Nov. 15, 2024 Young Scientists Shine at 5th Annual NOSTER & Science Microbiome Prize Ceremony KYOTO, Japan, Nov. 15, 2024 /PRNewswire/ -- Noster Inc. proudly hosted the 5th NOSTER & Science Microbiome Prize ...

International Cancer Organizations Present Collaborative Work During Oncology Event in China

PR Newswire XI'AN, China, Nov. 15, 2024 The National Comprehensive Cancer Network (NCCN) is honored to participate in the 4th International Congress of the Asian Oncology Society and the Chinese Congress on Holistic Integrative Oncology ...

Eupraxia Pharmaceuticals to Present at American College of Rheumatology Convergence 2024 Annual Meeting

PR Newswire VICTORIA, BC, Nov. 14, 2024 VICTORIA, BC, Nov. 14, 2024 /PRNewswire/ - Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX) (NASDAQ: EPRX), a clinical-stage biotechnology company leveraging its proprietary ...

The government of Canada and the government of Quebec announce $2.5 million in funding to fight addiction and prevent overdoses in the Eastern Townships

Canada NewsWire SHERBROOKE, QC, Nov. 14, 2024 Canada-Quebec Agreement on Addictions and Substance Use SHERBROOKE, QC, Nov. 14, 2024 /CNW/ - Toxic illegal drugs and overdoses are causing increasing harm across Canada, including here in ...

AZURITY PHARMACEUTICALS, INC ANNOUNCES FDA APPROVAL OF DANZITEN™ (nilotinib) tablets, THE FIRST AND ONLY NILOTINIB WITH NO MEALTIME RESTRICTIONS

PR Newswire WOBURN, Mass., Nov. 14, 2024 WOBURN, Mass., Nov. 14, 2024 /PRNewswire/ -- Azurity Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) has approved Danziten™, the first and only nilotinib with no ...

Eisai Receives Positive Opinion from the CHMP in the European Union for Lecanemab in Early Alzheimer's Disease

PR Newswire TOKYO and CAMBRIDGE, Mass., Nov. 14, 2024 TOKYO and CAMBRIDGE, Mass., Nov. 14, 2024 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: ...

Revolutionizing Heart Health: Frontier X Plus Gains FDA Clearance

PR Newswire NEW YORK, Nov. 13, 2024 NEW YORK, Nov. 13, 2024 /PRNewswire/ -- Fourth Frontier, a medical technology company based out of New York and Bangalore, announced the 510(k) clearance of the Frontier X Plus from the U.S. FDA. The ...

ImageBiopsy Lab launches IB Lab FROG: AI-powered Foot Measurements for Orthopedic Insights

PR Newswire VIENNA, Nov. 13, 2024 VIENNA, Nov. 13, 2024 /PRNewswire/ -- ImageBiopsy Lab, a leading provider of AI-powered musculoskeletal imaging solutions, has launched IB Lab FROG. This AI module, CE-cleared under the European Medical ...

Understanding Diabetes: HME Square Inc. is featured on Viewpoint with Dennis Quaid

PR Newswire MIAMI, Nov. 13, 2024 Millions of people across the United States navigate the challenges of diabetes, a complex condition that requires ongoing management. Viewpoint with Dennis Quaid sheds light on this journey, featuring HME ...

Cat Owners are Worried: New Survey Finds 54% of Cat Owners are Concerned about Litter Box Habits

PR Newswire MUSCATINE, Iowa, Nov. 13, 2024 World's Best Cat Litter® Introduces First Veterinary Approved Blood Detecting Litter Box Monitoring Solution: Health Check-In™ Boosters™ Litter Additive MUSCATINE, Iowa , Nov. 13, 2024 ...

Holiday Pie of Pet Dangers

PR Newswire MINNEAPOLIS, Nov. 13, 2024 Pet Toxicology Experts Slice Up a List of Common Yuletide Toxins MINNEAPOLIS, Nov. 13, 2024 /PRNewswire/ -- The perfect holiday season is filled with food, fun, family and friends. For your pets, ...

Eupraxia Pharmaceuticals Announces Positive Data from Fifth Cohort of RESOLVE Phase 1b/2a Trial of EP-104GI for Treatment of Eosinophilic Esophagitis

PR Newswire VICTORIA, BC, Nov. 12, 2024 VICTORIA, BC, Nov. 12, 2024 /PRNewswire/ - Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX) (NASDAQ: EPRX), a clinical-stage biotechnology company developing precision drug ...

Sanofi/Regeneron Pharmaceuticals' DUPIXENT Approval Marks a Significant Shift in Chronic Obstructive Pulmonary Disease Treatment Landscape | DelveInsight

PR Newswire LAS VEGAS, Nov. 12, 2024 After over a decade without notable progress in treating chronic obstructive pulmonary disease, patients with this ongoing condition now have two new treatment options, with more expected in the future. ...

Wound Care Market to Expand by USD 6.95 Billion (2024-2028), Revenue Boosted by Rising Acute and Chronic Cases, AI-Driven Report Highlights Market Shifts - Technavio

PR Newswire NEW YORK, Nov. 12, 2024 NEW YORK, Nov. 12, 2024 /PRNewswire/ -- Report with the AI impact on market trends - The global wound care market size is estimated to grow by USD 6.95 billion from 2024-2028, according to Technavio. The ...

Government of Canada increases reach of Canada Student Loan forgiveness for nurses and doctors in underserved rural and remote communities

Canada NewsWire SHEET HARBOUR, NS, Nov. 12, 2024 SHEET HARBOUR, NS, Nov. 12, 2024 /CNW/ - Canada is facing a shortage of health professionals, particularly in rural and remote communities that face unique challenges attracting and retaining ...

Get Gambit Redefines Men's Health with Convenient and Discreet Care, Specializing in Testosterone Replacement Therapy

Canada NewsWire TORONTO, Nov. 12, 2024 TORONTO, Nov. 12, 2024 /CNW/ - Get Gambit, a leading provider of healthcare solutions for men across Canada, is transforming the way men address critical health concerns. By offering discreet, ...

Viking Therapeutics to Present Data from Phase 2b VOYAGE Study of VK2809 in Patients with Biopsy-Confirmed NASH/MASH at the 75th Liver Meeting® 2024

PR Newswire SAN DIEGO, Nov. 12, 2024 Results to be Featured in Oral Late Breaker Presentation SAN DIEGO, Nov. 12, 2024 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company ...

Unlocking Hormone Health: Life Time to Host Complimentary Men's Hormone Health Livestream Nov. 13

PR Newswire CHANHASSEN, Minn., Nov. 12, 2024 Open to anyone via the Life Time App at Noon CT CHANHASSEN, Minn., Nov. 12, 2024 /PRNewswire/ -- Life Time (NYSE: LTH), which continues to innovate in the performance and longevity space ...

Annual Scientific Sessions for the Prevention of Cardiovascular Disease Coming to Boston's Seaport District August 2025

PR Newswire HOUSTON, Nov. 12, 2024 Pre-conference Course and General Session Registration Announcement for the American Society for Preventive Cardiology HOUSTON, Nov. 12, 2024 /PRNewswire/ -- The American Society for Preventive ...

My Green Mattress Announces Incredible Black Friday Sale: Give the Gift of Healthy Sleep

PR Newswire CHICAGO, Nov. 12, 2024 CHICAGO, Nov. 12, 2024 /PRNewswire/ -- My Green Mattress announces the biggest discounts of the year for their Black Friday Sale. Customers can enjoy exclusive pricing on premium, eco-friendly mattresses ...

Hunched App Expands to Android, Launches Updated iOS Version to Combat Text Neck Epidemic

PR Newswire MIAMI, Nov. 12, 2024 The App Expands its Commitment to Fight Text Neck with its Latest Innovation MIAMI, Nov. 12, 2024 /PRNewswire/ -- In today's digital age, posture-related issues like "Text Neck" and "Forward Head Posture" ...

Researchers uncover new role of mutant proteins in some of the deadliest cancers

PR Newswire BETHESDA, Md., Nov. 12, 2024 Findings could point to new ways to treat RAS-driven cancers BETHESDA, Md., Nov. 12, 2024 /PRNewswire/ -- Researchers at the National Institutes of Health (NIH) and their collaborators have ...

Ojjaara (momelotinib) approved in Canada for the treatment of myelofibrosis in adults who have moderate to severe anemia

Canada NewsWire MISSISSAUGA, ON, Nov. 12, 2024 MISSISSAUGA, ON, Nov. 12, 2024 /CNW/ - GSK announced today that Health Canada has approved Ojjaara (momelotinib) for the treatment of splenomegaly and/or disease-related symptoms, in adult ...

Neurologists Describe Early Detection of Alzheimer's Disease as 'Critical' for New Treatments

PR Newswire WASHINGTON, Nov. 12, 2024 Detection of Alzheimer's disease in its early stages is crucial to initiating treatment WASHINGTON, Nov. 12, 2024 /PRNewswire/ -- The availability of amyloid-reducing therapies now makes detection of ...

Gan & Lee Pharmaceuticals Announced Positive Phase 1 Results for Its Oral GLP-1 Receptor Agonist GZR18 Tablet in Healthy Participants, Demonstrating 4.16% Weight Reduction in Two Weeks

PR Newswire BEIJING, Nov. 12, 2024 BEIJING, Nov. 12, 2024 /PRNewswire/ -- Gan & Lee Pharmaceuticals (Gan & Lee, Shanghai Stock Exchange: 603087) announced the positive topline results of a Phase 1 clinical trial its oral glucagon-like ...

Access Accelerated and the World Bank Collaborate via New Technical Partnership in Cooperation with Results for Development to Build a Coalition Aimed at Closing the Health Financing Gap for Noncommunicable Diseases in Low and Middle-Income Countries

PR Newswire GENEVA and LILONGWE, Malawi, Nov. 12, 2024 GENEVA and LILONGWE, Malawi, Nov. 12, 2024 /PRNewswire/ -- Today marks the launch of a transformative initiative as Access Accelerated and the World Bank come together in a new technical ...

deCODE genetics/Amgen: New Study Explores the Role of BMI in Disease Risk

PR Newswire REYKJAVIK, Iceland, Nov. 12, 2024 REYKJAVIK, Iceland, Nov. 12, 2024 /PRNewswire/ -- New study from deCODE genetics/Amgen highlights the importance of BMI in pathogenesis of disease, suggesting that reducing BMI alone could lower ...

EDAN Unveils Latest Innovations for Global Healthcare at MEDICA 2024

PR Newswire DUSSELDORF, Germany, Nov. 12, 2024 DUSSELDORF, Germany, Nov. 12, 2024 /PRNewswire/ -- Edan Instruments Inc. (300206.SZ), a leading global provider of medical and healthcare solutions, showcased its latest product innovations at ...

Latest Press Releases

Premium Press Releases »

Philips Unveils Next-generation BlueSeal helium-free MRI system, Integrated with AI-enabled Smart Reading at #RSNA24

Boehringer’s focus on Health Equity drives significant upgrade in Access to Medicine Index Ranking

SurgiBox Announces Strategic Partnership with Accord International to Expand into Japanese Market

KFSHRC Introduces Pioneering Virtual Pathology Services in Madinah

Press Releases »

Foresee Pharmaceuticals Receives the Second Positive Recommendation from DSMB to Continue the Casppian Study, a Phase 3 Clinical Trial of Leuprolide (FP-001) Injectable Emulsion for the Treatment of Central Precocious Puberty

Immunovia presents model-development study results at meeting of the Collaborative Group of the Americas--Inherited Gastrointestinal Cancers

Noster Inc research: Celebrating Breakthroughs in Gut Microbiome

International Cancer Organizations Present Collaborative Work During Oncology Event in China

Eupraxia Pharmaceuticals to Present at American College of Rheumatology Convergence 2024 Annual Meeting

The government of Canada and the government of Quebec announce $2.5 million in funding to fight addiction and prevent overdoses in the Eastern Townships

AZURITY PHARMACEUTICALS, INC ANNOUNCES FDA APPROVAL OF DANZITEN™ (nilotinib) tablets, THE FIRST AND ONLY NILOTINIB WITH NO MEALTIME RESTRICTIONS

Eisai Receives Positive Opinion from the CHMP in the European Union for Lecanemab in Early Alzheimer's Disease

Revolutionizing Heart Health: Frontier X Plus Gains FDA Clearance

ImageBiopsy Lab launches IB Lab FROG: AI-powered Foot Measurements for Orthopedic Insights

Understanding Diabetes: HME Square Inc. is featured on Viewpoint with Dennis Quaid

Cat Owners are Worried: New Survey Finds 54% of Cat Owners are Concerned about Litter Box Habits

Holiday Pie of Pet Dangers

Eupraxia Pharmaceuticals Announces Positive Data from Fifth Cohort of RESOLVE Phase 1b/2a Trial of EP-104GI for Treatment of Eosinophilic Esophagitis

Sanofi/Regeneron Pharmaceuticals' DUPIXENT Approval Marks a Significant Shift in Chronic Obstructive Pulmonary Disease Treatment Landscape | DelveInsight

Wound Care Market to Expand by USD 6.95 Billion (2024-2028), Revenue Boosted by Rising Acute and Chronic Cases, AI-Driven Report Highlights Market Shifts - Technavio

Government of Canada increases reach of Canada Student Loan forgiveness for nurses and doctors in underserved rural and remote communities

Get Gambit Redefines Men's Health with Convenient and Discreet Care, Specializing in Testosterone Replacement Therapy

Viking Therapeutics to Present Data from Phase 2b VOYAGE Study of VK2809 in Patients with Biopsy-Confirmed NASH/MASH at the 75th Liver Meeting® 2024

Unlocking Hormone Health: Life Time to Host Complimentary Men's Hormone Health Livestream Nov. 13

Annual Scientific Sessions for the Prevention of Cardiovascular Disease Coming to Boston's Seaport District August 2025

My Green Mattress Announces Incredible Black Friday Sale: Give the Gift of Healthy Sleep

Hunched App Expands to Android, Launches Updated iOS Version to Combat Text Neck Epidemic

Researchers uncover new role of mutant proteins in some of the deadliest cancers

Ojjaara (momelotinib) approved in Canada for the treatment of myelofibrosis in adults who have moderate to severe anemia

Neurologists Describe Early Detection of Alzheimer's Disease as 'Critical' for New Treatments

Gan & Lee Pharmaceuticals Announced Positive Phase 1 Results for Its Oral GLP-1 Receptor Agonist GZR18 Tablet in Healthy Participants, Demonstrating 4.16% Weight Reduction in Two Weeks

Access Accelerated and the World Bank Collaborate via New Technical Partnership in Cooperation with Results for Development to Build a Coalition Aimed at Closing the Health Financing Gap for Noncommunicable Diseases in Low and Middle-Income Countries

deCODE genetics/Amgen: New Study Explores the Role of BMI in Disease Risk

EDAN Unveils Latest Innovations for Global Healthcare at MEDICA 2024

Medindia Newsletters